First Report of Tocilizumab Use in a Cohort of Latin American Patients Hospitalized for Severe COVID-19 Pneumonia

Introduction/objectives: An interleukin-6 inhibition strategy could be effective in selected COVID-19 patients. The objective is to present our experience of tocilizumab use in patients with severe COVID-19. Methods: Observational retrospective cohort study. Hospitalized patients were evaluated by o...

Descripción completa

Detalles Bibliográficos
Autores principales: Valenzuela, Omar, Ibáñez, Sebastián, Poli, M. Cecilia, Roessler, Patricia, Aylwin, Mabel, Roizen, Gigia, Iruretagoyena, Mirentxu, Agar, Vivianne, Donoso, Javiera, Fierro, Margarita, Montes, José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701172/
https://www.ncbi.nlm.nih.gov/pubmed/33304913
http://dx.doi.org/10.3389/fmed.2020.596916

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701172/
https://www.ncbi.nlm.nih.gov/pubmed/33304913
http://dx.doi.org/10.3389/fmed.2020.596916

Ejemplares similares